Back to search

University of South Florida

Changes In Immune-Regulated Gene Methylation Over Time in Women Who Do and Do Not Develop Breast Cancer

Abstract

dc:description

Breast cancer survivors face elevated risks of chronic inflammatory conditions and immunedysfunction compared to the general population. These elevated health risks in survivors are well-documented but mechanistically poorly understood. This study aimed to characterize longitudinal changes in DNA methylation patterns of immune-regulatory genes in women who developed breast cancer compared to cancer-free controls. We conducted an EWAS using Sister Study cohort data, analyzing longitudinal changes in DNA methylation by comparing the difference in beta values between pre- and post-diagnosis time points in breast cancer cases versus changes over the same period in cancer-free controls. The analysis included 414 participants: 189 women diagnosed with breast cancer between two blood draws and 225 cancer- free controls, with a mean interval of 7.7 years between the two blood collections. DNA methylation was measured in blood samples collected before and after breast cancer diagnosis and treatment. We focused on CpG sites associated with key immune-regulatory genes: TNF, IL- 6, IL-16, CCL2, CCL21 and CCL24. Four progressive statistical models were used: crude, age- adjusted, patient characteristics, and fully adjusted. We examined associations with and without adjustment for patient age (baseline and age difference), body mass index (baseline and age difference), race, treatment modalities (chemotherapy, radiation, endocrine therapy), and immune cell composition (CD4+ T cells, CD8+ T cells, monocytes, neutrophils, and NK cells). Significant differences in leukocyte composition emerged over time. The EWAS identified 1,647 CpG sites related to immune markers, with TNF, IL-6, and IL-16 genes prominently represented among the top findings across all models. Of these 1,647 immune-regulatory CpG sites, 95 to 100 sites showed nominally significant associations (p < 0.05) that warrant further investigation in larger studies. This study provides suggestive but statistically non-significant evidence for distinct DNA methylation patterns that warrant validation in larger studies. Consistent methylation signatures across models suggest coordinated epigenetic reprogramming following cancer treatment. While results did not reach statistical significance after multiple testing correction, the biological coherence and consistency of findings warrant validation in larger, independent cohorts. Future research should investigate whether these methylation signatures predict long-term health outcomes and could inform personalized survivorship care strategies.

Degree

thesis:*
Name thesis:degree_name
Master of Science (M.S.)
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Public Health
Grantor
University of South Florida
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Laney, Kyle
Contributors dc:contributor
  • Xiaoming Liu, Ph.D.
  • Jacob Kresovich, Ph.D.
  • Dominic D'Agostino, Ph.D.
  • Kathleen Egan, Sc.D.

Subjects

dc:subject × 6

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10877

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Laney, Kyle. Changes In Immune-Regulated Gene Methylation Over Time in Women Who Do and Do Not Develop Breast Cancer. Thesis thesis, University of South Florida, 2025. https://digitalcommons.usf.edu/etd/10877